Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.\new Filed Acc 0001144204-08-006888

Options or other derivatives

  • Chief Financial Officer acquired 27,042 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

HARVEY DANIEL · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2008-02-04 Grant or award : show line 1 in the form Stock Option (Right to Buy) +13,521 13,521 D
2008-02-04 Grant or award : show line 2 in the form Stock Option (Right to Buy) +13,521 13,521 D
Loading xslF345X02/v102281_ex.xml…